![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 2
2018
Muckenhuber, Alexander; Berger, Anne Katrin; Schlitter, Anna Melissa; Steiger, Katja; Konukiewitz, Björn; Trumpp, Andreas; Eils, Roland; Werner, Jens; Friess, Helmut; Esposito, Irene; Kloeppel, Guenter; Ceyhan, Gueralp O.; Jesinghaus, Moritz; Denkert, Carsten; Bahra, Marcus; Stenzinger, Albrecht; Sprick, Martin R.; Jaeger, Dirk; Springfeld, Christoph und Weichert, Wilko
(2018):
Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment Response.
In: Clinical Cancer Research, Bd. 24, Nr. 2: S. 351-359
2016
Noll, Elisa M.; Eisen, Christian; Stenzinger, Albrecht; Espinet, Elisa; Muckenhuber, Alexander; Klein, Corinna; Vogel, Vanessa; Klaus, Bernd; Nadler, Wiebke; Rösli, Christoph; Lutz, Christian; Kulke, Michael; Engelhardt, Jan; Zickgraf, Franziska M.; Espinosa, Octavio; Schlesner, Matthias; Jiang, Xiaoqi; Kopp-Schneider, Annette; Neuhaus, Peter; Bahra, Marcus; Sinn, Bruno V.; Eils, Roland; Giese, Nathalia A.; Hackert, Thilo; Strobel, Oliver; Werner, Jens; Büchler, Markus W.; Weichert, Wilko; Trumpp, Andreas und Sprick, Martin R.
(2016):
CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma.
In: Nature Medicine, Bd. 22, Nr. 3: S. 278-287